Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what ...

Since Kennedy suspended his campaign and endorsed Trump in August, Shanahan, 39, has rebranded herself as a wellness guru promising to “Make America Healthy Again” (MAHA). She has disavowed members of ...

Me is facing scrutiny, with some experts calling it the beginning of the end for the popular genetic testing company. It's ...

In this podcast, Motley Fool analyst Jason Moser and host Mary Long discuss the semiconductor supply chain, ASML's earnings, ...

The entire board of DNA testing company 23andMe resigned after a conflict with CEO Anne Wojcicki over her plan to take the ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

A giant biotechnology company might be about to go bust. What will happen to the millions of people’s DNA it holds?

Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

Ambience Healthcare - the leading clinical AI platform for scribing, point-of-care CDI, patient summaries, and referrals - today announced that it has received a 97.7%* Spotlight Report score from ...

Turmoil at 23andMe, and a lawsuit alleging that GEDmatch shares data with Facebook, highlights how far your genetic ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...